Catalyst Financial Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.45M | Sell |
13,181
-155
| -1% | -$28.8K | 0.27% | 38 |
|
|
2025
Q1 | $2.79M | Buy |
13,336
+504
| +4% | +$106K | 0.51% | 30 |
|
|
2024
Q4 | $2.28M | Buy |
12,832
+363
| +3% | +$64.5K | 0.43% | 32 |
|
|
2024
Q3 | $2.46M | Buy |
12,469
+173
| +1% | +$34.2K | 0.48% | 31 |
|
|
2024
Q2 | $2.11M | Buy |
12,296
+1,078
| +10% | +$185K | 0.46% | 32 |
|
|
2024
Q1 | $1.84M | Buy |
11,218
+316
| +3% | +$51.9K | 0.47% | 31 |
|
|
2023
Q4 | $1.69M | Buy |
10,902
+296
| +3% | +$45.9K | 0.48% | 34 |
|
|
2023
Q3 | $1.58M | Buy |
10,606
+1,767
| +20% | +$263K | 0.51% | 32 |
|
|
2023
Q2 | $1.19M | Sell |
8,839
-440
| -5% | -$59.3K | 0.42% | 34 |
|
|
2023
Q1 | $1.48M | Buy |
9,279
+635
| +7% | +$101K | 0.63% | 27 |
|
|
2022
Q4 | $1.4M | Buy |
+8,644
| New | +$1.4M | 0.72% | 27 |
|